Clinical and extinguished no hepatitis B playing interferon chances of success, patients need to strictly comply with the doctor’s instructions to inject interferon.
Usually, patients with chronic hepatitis B can be treated with interferon drugs as prescribed by the doctor, mainly available ordinary interferon-α and polyethylene glycol interferon-α. The drug belongs to the injection, mainly used for antiviral treatment, but there is no interferon for hepatitis B with a high chance of success.
Generally for the young, hope to have children in recent years, expect to complete the treatment in a short period of time, as well as the first time to receive antiviral treatment patients, can be preferred to use polyethylene glycol interferon-α, belongs to the long-acting preparation, its antiviral effect is better than the ordinary interferon-α. The commonly used clinical drugs are polyethylene glycol interferon alpha-2a and polyethylene glycol interferon alpha-2b, and the course of treatment is 1 year.
However, patients who already have decompensated cirrhosis, serum bilirubin greater than or equal to two times the upper limit of normal value, symptomatic pregnancy or short-term planned pregnancy should not undergo interferon therapy. Interferon therapy is also not allowed if the patient has severe cardiac or renal disease, hyperthyroidism, psychoneurological abnormalities, diabetes and other vital organ pathologies.
Hepatitis B patients are advised to take reasonable treatment strictly under the guidance of the doctor and do a good job in their daily care.